140 related articles for article (PubMed ID: 2767522)
1. Flow cytometric DNA analysis of stage I endometrial carcinoma.
Britton LC; Wilson TO; Gaffey TA; Lieber MM; Wieand HS; Podratz KC
Gynecol Oncol; 1989 Sep; 34(3):317-22. PubMed ID: 2767522
[TBL] [Abstract][Full Text] [Related]
2. DNA ploidy in endometrial carcinoma: major objective prognostic factor.
Britton LC; Wilson TO; Gaffey TA; Cha SS; Wieand HS; Podratz KC
Mayo Clin Proc; 1990 May; 65(5):643-50. PubMed ID: 2348728
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
Takahashi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma.
Iversen OE
Am J Obstet Gynecol; 1986 Oct; 155(4):770-6. PubMed ID: 3766632
[TBL] [Abstract][Full Text] [Related]
5. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
[TBL] [Abstract][Full Text] [Related]
6. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
7. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator.
Rosenberg P; Wingren S; Simonsen E; Stàl O; Risberg B; Nordenskjöld B
Gynecol Oncol; 1989 Oct; 35(1):50-4. PubMed ID: 2792902
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
[TBL] [Abstract][Full Text] [Related]
11. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
Zanetta GM; Katzmann JA; Keeney GL; Kinney WK; Cha SS; Podratz KC
Gynecol Oncol; 1992 Jul; 46(1):13-9. PubMed ID: 1634134
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
[TBL] [Abstract][Full Text] [Related]
13. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma.
Miller J; Horsfall DJ; Marshall VR; Rao DM; Leong SY
J Urol; 1991 Jun; 145(6):1192-6. PubMed ID: 2033691
[TBL] [Abstract][Full Text] [Related]
18. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy and steroid receptors as predictors of disease course in patients with endometrial carcinoma.
Iversen OE; Utaaker E; Skaarland E
Acta Obstet Gynecol Scand; 1988; 67(6):531-7. PubMed ID: 3239384
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
